FDA News Boosts Trimedyne Shares 33%
Dow Jones
Trimedyne Inc.’s stock rose 33% Wednesday after the Irvine company said it received permission from the Food and Drug Administration to market Holmium lasers and related disposable devices for a variety of surgical procedures.
The medical laser company’s stock closed at $2.53 a share, up 63 cents. A total of 644,200 shares changed hands in Nasdaq trading, more than six times the average daily volume over the last three months.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
